norethindrone has been researched along with estropipate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varma, TR | 2 |
| Morsman, J; Varma, TR | 1 |
| King, RJ; Pryse-Davies, J; Ryder, TA; Townsend, PT; Whitehead, MI | 1 |
| Daly, M; Friedman, AJ; Gleason, R; Juneau-Norcross, M; LeBoff, M; Rein, MS | 1 |
| Broverman, DM; Klaiber, EL; Peterson, LG; Snyder, MB; Vogel, W | 1 |
| Alexandersen, P; Byrjalsen, I; Christiansen, C | 2 |
4 trial(s) available for norethindrone and estropipate
| Article | Year |
|---|---|
Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
Topics: Adult; Bone Density; Cholesterol, HDL; Delayed-Action Preparations; Estradiol Congeners; Estrone; Female; Hematocrit; Humans; Leiomyoma; Leuprolide; Middle Aged; Norethindrone; Prospective Studies; Time Factors; Uterine Neoplasms | 1994 |
Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women.
Topics: Affect; Blood Platelets; Climacteric; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Gonadal Steroid Hormones; Humans; Individuality; Middle Aged; Monoamine Oxidase; Norethindrone | 1996 |
Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium.
Topics: Administration, Oral; Endometrium; Estrone; Female; Hormone Replacement Therapy; Humans; Norethindrone; Postmenopause; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 2000 |
Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects.
Topics: Aged; Bone Density; Climacteric; Drug Therapy, Combination; Estrone; Female; Humans; Lipoproteins; Middle Aged; Norethindrone; Progesterone Congeners; Prospective Studies | 2000 |
4 other study(ies) available for norethindrone and estropipate
| Article | Year |
|---|---|
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Topics: Adult; Aged; Cholesterol; Clonidine; Dydrogesterone; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners; Time Factors | 1983 |
Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.
Topics: DNA; Dose-Response Relationship, Drug; Endometrium; Estradiol; Estradiol Congeners; Estradiol Dehydrogenases; Estrogens; Estrone; Female; Humans; Isocitrate Dehydrogenase; Menopause; Norethindrone; Norgestrel; Piperazines; Progestins; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone | 1981 |